Financials and Filings FINANCIALS AND FILINGS submenu Overview SEC Filings Annuals & Proxies Quarterly Results Key Ratios Show all 2023 Third Quarter Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance Form 10-Q Filing date View November 02, 2023 View HTML 0001628280-23-036217.pdf 0001628280-23-036217.rtf 0001628280-23-036217.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA August 03, 2023 View HTML 0001628280-23-027013.pdf 0001628280-23-027013.rtf 0001628280-23-027013.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-K Filing date View March 01, 2023 View HTML 0001193125-23-055176.pdf 0001193125-23-055176.rtf 0001193125-23-055176.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA March 01, 2022 View HTML 0001193125-22-059849.pdf 0001193125-22-059849.rtf 0001193125-22-059849.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Proxy Statements Filing date View April 28, 2023 View HTML 0001193125-23-127257.pdf 0001193125-23-127257.xls 0001193125-23-127257.rtf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA April 21, 2022 View HTML 0001193125-22-113145.pdf 0001193125-22-113145.xls 0001193125-22-113145.rtf
